Skip to main content

RT @drpnash: Toll-like Receptor Inhibitor Peptide Improves the Clinical, Immunologic, and Pathologic Manifestations of S

Social Author Name
Peter Nash
Tweet Content
Toll-like Receptor Inhibitor Peptide Improves the Clinical, Immunologic, and Pathologic Manifestations of Systemic Lupus Erythematosus https://t.co/hAqngljp2b #sle #tollreceptorinhib TLR inhib in mice for SLE
Show on Archive Page
On
Display in Search Results
On